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Setting the stage for increasing diversity
in congenital cardiology: let’s celebrate
the 75th anniversary of the Blalock–
Thomas–Taussig shunt
Quint A. J. Hagdorn and Rolf M. F. Berger
Center for Congenital Heart Diseases, Department of Pediatric Cardiology, University Medical Center Groningen,
University of Groningen, Groningen, The Netherlands
Dear editor,
Recently, the Editors of the Lancet Group announced a laudable “Diversity Pledge” to
increase gender equity, diversity, and inclusion in research.1 They also encouraged members
of the scientific community to contribute to this initiative. This year’s 75th anniversary of a
landmark medical achievement provides the perfect opportunity for the congenital cardiology
community to follow their lead.
In 1944, the first surgical creation of a systemic-to-pulmonary shunt was successfully per-
formed in a blue baby, as a surgical palliative treatment for tetralogy of Fallot.2 Helen Taussig,
a White paediatric cardiologist at John Hopkins Hospital, realised that infants with severe
cyanosis would benefit from an assured pulmonary blood flow. She therefore challenged
Alfred Blalock, head of surgery at John Hopkins and also White, to surgically create a similar
type of shunt.3 This procedure, which became known as the Blalock–Taussig shunt, has
prolonged thousands of lives and spearheaded the development of heart surgery for CHD.
However, it is nowadays generally acknowledged that a third person played a key role in leading
this life-saving surgical procedure into clinical practice: Vivien Thomas, Blalock’s African-
American laboratory assistant. He first developed the technique in a myriad of laboratory dogs,
then adapted the instruments for human use, and eventually coached Blalock through the first
operations on infants.4,5
In those times of racial segregation, Thomas did not share in the fame and recognition that
Blalock and Taussig received after publishing this landmark achievement. As a Black, non-
degreed laboratory assistant Thomas was initially not included in any form of publicity nor
acknowledged for his undisputed experimental and clinical contributions. Decades later,
attempts weremade to alleviate this inequity: Thomas was awarded an honorary Doctor’s degree
by Johns Hopkins University. Yet, despite earlier suggestions to rename the Blalock–Taussig
shunt into the Blalock–Thomas–Taussig shunt5–7, trivial arguments as “it would be impractical
to change the name of the shunt”6 have apparently precluded to provide Vivien Thomas the
deserved honour of having the shunt named after him.
Let us now put this Diversity Pledge into practice, and rename the Blalock–Taussig shunt to
the Blalock–Thomas–Taussig shunt, as a shining example to support and encourage diversity.
The Blalock–Thomas–Taussig shunt would not only rightfully honour Vivien Thomas but also
repeatedly remind us to value intellectual contribution instead of race, gender, socio-economic
status, or other factors that may influence authorship until today. Especially in paediatrics and
adolescent medicine, such statements are encouraged and highly needed.8 We therefore call on
the congenital cardiology community to follow the laudable initiative of the Editors of the Lancet
Group: let us celebrate the 75th anniversary of this landmark achievement and, instead of the
former Blalock–Taussig shunt, from today on use the name Blalock–Thomas–Taussig shunt.
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